Normal view MARC view ISBD view

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

Rasmussen, B B

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors? [electronic resource] - Therapeutic drug monitoring Apr 2000 - 143-54 p. digital

Publication Type: Journal Article; Review

ISSN: 0163-4356

Standard No.: 10.1097/00007691-200004000-00001 doi

Subjects--Topical Terms:
Biotransformation
Cytochrome P-450 Enzyme System--physiology
Drug Interactions
Drug Monitoring
Humans
Selective Serotonin Reuptake Inhibitors--blood

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)